INNOVATIVE SOLUTIONS

Personalized, Effective & Safe

Cognitive Behavioral Therapy

Cognitive behavioral therapy (CBT) is a skill-based talk therapy focused on the relationship between a person’s thoughts, feelings and behaviors. Individuals with depression or anxiety often have pervasive, unrealistic, negative thoughts that adversely shape the way they view themselves, their environment and their prospects for the future. These thoughts can then lead to feelings of depression or anxiety, and if they persist, can interfere with relationships or level of functioning. CBT aims to provide a set of tools that allow the patient to manage negative thoughts by doing things like questioning the validity of these thoughts, altering one’s negative core beliefs, and ultimately changing one’s behaviors. CBT has been widely studied and proven to be effective for those who are able to incorporate these tools into their lives.

Telepsychiatry

Telepsychiatry is the delivery of psychiatric assessment and care via live video conferencing. During telepsychiatry sessions, the patient and provider can see, hear, and interact with one another in real time. Our providers are experts in the treatments most likely to help the depressive or anxious symptoms you are experiencing. Both in-person and telepsychiatry appointments follow the same clinical guidelines; treatment plans, including prescription medicine, can be created and implemented at both.

Spravato

Spravato (nasal esketamine) has been FDA-approved for the treatment of depression in patients who have not responded to 2 or more treatments. This is the first truly new FDA-approved medication option for depression in 60 years. Esketamine, also called s-ketamine, is “one half” of ketamine ⁠— the other half being r-ketamine, its mirror image molecule. Esketamine is a nasal spray, administered in a certified office setting by psychiatrists, that may more rapidly treat depression than conventional antidepressants. Side effects may be experienced for about an hour while taking it; side effects may include a dreamlike or “floaty” feeling, nausea, headache, or brief and mild elevations in blood pressure. There is a 2-hour observation time after nasal administration. Spravato is covered by some insurers for depression treatment and Actify is actively enrolling in those plans for direct coverage.

Transcranial Magnetic Stimulation

Transcranial Magnetic Stimulation (TMS) is an FDA-approved treatment for depression that is a non-invasive, in-office, well-tolerated procedure. TMS uses an MRI-strength magnetic coil to deliver a low-energy pulse to a targeted area of the brain. This is a non-invasive procedure that does not involve medication. Treatment is delivered on a Monday through Friday basis for 4-6 weeks, and then tapered off. Time in the office is approximately 30 minutes, and patients may drive themselves. Results are typically seen within the first 2-3 weeks. TMS is directly insurance-covered by most plans for treatment resistant depression, but may also be delivered off-label for OCD, PTSD, and other anxiety disorders.

Ketamine Infusion Therapy

Ketamine infusion therapy is a treatment option for depression and some anxiety disorders. Some people do not respond sufficiently to traditional treatment plans, which usually consist of SSRI antidepressants and talk therapy. Patients are connected to an IV and administered a very low dose of ketamine for about 40 minutes. Potential side effects may occur during the infusion including nausea, elevation of blood pressure, dissociation, or headache. Ketamine infusion therapy is a safe, evidence-based, rapid-acting option to help manage treatment-resistant depression and anxiety symptoms. Earlier research and experience with IV ketamine led to the development and approval of Spravato.

CMO

Dr. Steve Levine

Dr. Steve Levine is a board-certified psychiatrist internationally recognized for his contributions to advancements in mental health care. Though he is a psychiatrist who places great emphasis on the importance of psychotherapy, medication is often a necessary component of treatment, and he was dissatisfied with the relatively ineffective available options with burdensome side effects. Dr. Levine pioneered a protocol for the clinical use of ketamine infusions, has directly supervised many thousands of infusions and has helped establish similar programs across the country and around the world. Dr. Levine completed internship and residency in psychiatry at New York – Presbyterian Hospital – Weill Cornell. He then completed fellowship subspecialty training in psychosomatic medicine/psycho-oncology at Memorial Sloan Kettering Cancer Center/New York Presbyterian Hospital.

CEO

Kathy Kaluhiokalani

As the CEO of Actify, Kathy Kaluhiokalani is responsible for running all facets of the business. She is passionate about providing access to next generation, best-in-class mental healthcare treatment for those dealing with major depressive and anxiety disorders. Prior to joining Actify, Kathy was the Chief Operating Officer for MedExpress Urgent Care, an Optum Company. She was responsible for leading the center level operations of 250+ locations nationwide. Prior to MedExpress, Kathy worked for the University of Pittsburgh Medical Center (UPMC) in various roles for both Physician Services as well as Corporate Services. She earned her BA degree at the University of Maryland, Baltimore County, where she graduated summa cum laude. Kathy brings extensive healthcare leadership experience to Actify and is excited to lead our mission of evidence based, compassion driven mental healthcare delivery.

We Save Lives

Actify is a warm and personalized place to get the most advanced care available. We look forward to liberating you from outdated treatments and side effects.

50,000
TREATMENTS
5,000
PATIENTS
9
LOCATIONS

Scientific Advisory Board

Our research-backed, data-driven treatment protocols have been developed with guidance from our Scientific Advisory Board. We are proud to be backed by the leading researchers and thought leaders in mental health innovation.

Charles B. Nemeroff, MD, PhD
Professor and Acting Chair of Psychiatry
Associate Chair for Research
Director, Institute of Early Life Adversity Research
 Dell Medical School | The University of Texas at Austin
Pierre Blier, MD, PhD
Research Chair and Director, Mood Disorders Research Unit
The Royal’s Institute of Mental Health Research
Professor, Dept. of Psychiatry & Cellular and Molecular Medicine
University of Ottawa
David V. Sheehan, MD MBA DLFAPA
Distinguished University Health Professor Emeritus
University of South Florida College of Medicine
Distinguished Life Fellow, American Psychiatric Association
Mark A. Frye, MD
Professor and Chair, Department of Psychiatry and Psychology
Stephen & Shelly Jackson Family Professorship in Individualized Medicine
Director, Mayo Clinic Depression Center
Mayo Clinic

EMERGE FROM THE SHADOWS

Creating Lasting Mental Wellbeing

Depression
Depression is a common, but serious, mood disorder. It causes severe symptoms that affect how you feel and think, as well as manage daily activities such as sleeping, eating, or working. Depression is a treatable condition, and for the first time in 50 years, depression treatments are available that do not require taking daily medications that can cause side effects.
DEPRESSION
Anxiety
Generalized anxiety disorder includes symptoms of persistent and excessive worry about activities or events — even ordinary, routine issues. While everyone experiences nervousness, anxiety disorders have a debilitating impact on an individual’s productivity and relationships. With the right treatment, symptoms of anxiety can be managed.
ANXIETY
Post-Traumatic Stress Disorder
Post-traumatic stress disorder (PTSD) can occur in people who have experienced or witnessed a traumatic event. Nearly everyone will experience a range of reactions after trauma, yet most people recover from initial symptoms without treatment. Those who continue to have disruptive experiences may be diagnosed with PTSD. People who have PTSD may feel stressed or frightened, even when they are not in danger. PTSD treatment often combines therapy and medication.
PTSD
Obsessive-Compulsive Disorder
Obsessive-compulsive disorder is an anxiety disorder characterized by persistent unwanted thoughts, fears, or other feelings that lead to compulsive behaviors. OCD often centers on themes such as fear of germs, the need to count objects, or the urge to complete rituals before feeling calm. Symptoms usually begin gradually and vary throughout life, at times becoming overwhelming.
OCD

PEACE OF MIND

Connect Us with Your Patients

Leave us your name email and we will provide information on how to refer your patients to Actify